AstraZeneca and Johnson & Johnson to resume COVID-19 vaccine trials as U.S. daily cases top 71,000 - CBS News

On Friday, both AstraZeneca and Johnson & Johnson announced that their coronavirus vaccine trials are set to resume in the U.S.

The Food and Drug Administration gave the green light after investigations found no link between those cases and the vaccine.

In hot spot Wisconsin, new cases are up nearly 40% compared to two weeks ago.

Katelyn Evans, 16, became the first teen to get an injection as part Pfizer's COVID-19 vaccine study at Cincinnati Children's Hospital, the Associated Press reported.

"I figured, you know, the more people they test, the more information they get and the sooner they can put out a vaccine to keep everyone safe," said Evans.